Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 286193

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryA phase I trial of 2-β-D-ribofuranosylthiazole-4-carboxamide (NCS 286193, tiazofurin) was conducted using a 5-day i.v… Expand
  • table 1
  • table 2
  • table 3
1990
1990
The authors studied the metastasis-inhibiting effect of various dosages of tiazofurin in mice inoculated with a low (LLT) and a… Expand
Highly Cited
1989
Highly Cited
1989
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193), a selective inhibitor of the activity of IMP dehydrogenase… Expand
  • figure I
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
1988
Highly Cited
1988
Tiazofurin (2-beta-D-ribofuranosyl-4-thiazole-carboxamide; NSC 286193), an antitumor carbon-linked nucleoside that inhibits IMP… Expand
  • figure 2
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Highly Cited
1987
Highly Cited
1987
A patient with refractory acute myeloid leukemia was treated with tiazofurin, an agent that causes inhibition of tumor cell… Expand
  • figure 1
1985
1985
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, TCAR, Riboxamide, NSC 286193) is a novel C-nucleoside with antitumor… Expand
1985
1985
A Phase I trial of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193, tiazofurin) was conducted using a 5-day continuous… Expand
1985
1985
Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide), a new nucleoside antimetabolite, was evaluated in a phase I trial… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
1982
Highly Cited
1982
Studies on the mechanism of action of a new oncolytic nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide, have been undertaken… Expand
1982
1982
Administration of the novel thiazole C-nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193), to BDF1 mice… Expand